Combination of Rapamycin and MK-2206 Induced Cell Death via Autophagy and Necroptosis in MYCN-Amplified Neuroblastoma Cell Lines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination of Rapamycin and MK-2206 Induced Cell Death via Autophagy and Necroptosis in MYCN-Amplified Neuroblastoma Cell Lines

Published:2020-02-14 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Dong Yudi,Gong Wei,Hua Zhongyan,Chen Bo,Zhao Guifeng,Liu Zhihui,Thiele Carol J.,Li Zhijie

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference44 articles.

1. Rapamycin passes the torch: a new generation of mTOR inhibitors;Benjamin;Nat. Rev. Drug Discovery,2011

2. Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma;Boboila;Oncogene,2018

3. Co-treatment of LY294002 or MK-2206 with AZD5363 Attenuates AZD5363-induced increase in the level of phosphorylated AKT;Choi;Anticancer Res.,2016

4. MYCN amplification remains prognostically strong 20 years after its “clinical debut;Cohn;Eur. J. Cancer,2004

5. Differential effects of the Akt inhibitor MK-2206 on migration and radiation sensitivity of glioblastoma cells;Djuzenova;BMC Cancer,2019

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SESN1 functions as a new tumor suppressor gene via Toll‐like receptor signaling pathway in neuroblastoma;CNS Neuroscience & Therapeutics;2024-03

2. Targeting autophagy drug discovery: Targets, indications and development trends;European Journal of Medicinal Chemistry;2024-03

3. Alcohol induces hepatocytes necroptosis through the LC3/RIPK1/RIPK3 pathway;Food and Chemical Toxicology;2023-12

4. AKT Inhibitor MK-2206 Attenuates Sepsis Acute Lung Injury (SALI) by Regulating Macrophage Polarization and Apoptosis;J BIOL REG HOMEOS AG;2023

5. GAPDH in neuroblastoma: Functions in metabolism and survival;Frontiers in Oncology;2022-10-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3